Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Transcranial Magnetic Stimulation (TMS) as a Surrogate of Pathophysiology in Genetic Epilepsies

NCT06284291 is registered in ClinicalTrials.gov with Meyer Children's Hospital IRCCS as lead sponsor.

NCT NCT06284291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06284291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Transcranial Magnetic Stimulation (TMS) as a Surrogate of Pathophysiology in Genetic Epilepsies
Lead sponsor
Meyer Children's Hospital IRCCS
Phase
Not applicable
Overall status
Unknown status
Start date
November 22, 2023
Completion date
March 1, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, genetic disease